OSE Immunotherapeutics Announces Temporary Pause of Patient Accrual
OSE Immunotherapeutics Announces Temporary Pause of Patient Accrual While Continuing Treatment for Patients Already Enrolled In Phase 3 Clinical Trial... View Article
OSE Immunotherapeutics Receives Payment of €2.6 Million from Bpifrance
OSE Immunotherapeutics Receives Payment of €2.6 Million from Bpifrance After Completion of a New Key Milestone for its Product OSE-127... View Article
OSE Immunotherapeutics Announces Strategic Multi-Year Research Collaboration with Memorial Sloan Kettering Cancer Center
OSE Immunotherapeutics Announces Strategic Multi-Year Research Collaboration with Memorial Sloan Kettering Cancer Center in New York Focused on Company’s Cytotoxic... View Article
What’s up France Biotech
After Paris, Lille and Marseille, France Biotech stopped over in Nantes to present an overview of the Life Science industry... View Article
IHU-CESTI : Epigenetics expert Jérémie Poschmann chooses Nantes
Attracting highly-talented researchers is certainly one of the great strengths of the Nantes IHU CESTI, in particular through the « Attractiveness »... View Article
Valneva to Present at Jefferies 2017 Global Healthcare Conference in New York
Valneva, a fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines, today announced that Thomas Lingelbach, President... View Article
In Cell Art ’s co-founder invited to present at the SF Nano Summer School
In Cell Art, a biotechnology company specializing in nanocarrier technologies named Nanotaxi® for unlocking the promise of nucleic acids to... View Article
Lemer Pax: Posijet®, the history of an exemplary partnership
The latest version of Posijet®, a mobile unit for the preparation and injection of high-energy radiopharmaceuticals, has become the compact... View Article
OSE Immunotherapeutics: last news
OSE Immunotherapeutics present significant data on Selective Anti-SIRPa OSE-172 (Effi-DEM) OSE Immunotherapeutics announced that the Company presented in oral session significant data on... View Article
Portrait Olivier KITTEN, Affilogic
Olivier KITTEN, Founder & CEO Affilogic Atlanpole: What is the pitch of your business? Olivier Kitten: Affilogic is a... View Article